• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
    • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    19th Annual Salary & Job Satisfaction Survey
    Newsmakers: Flash Therapeutics
    DCAT Sharp Sourcing 2018
    Pre-clinical CRO Evaluation
    Journeying with CROs: Driving drug development efficiency
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Aclaris Therapeutics Announces Key Hires
    Recipharm, SERB Enter Agreement
    ACM Global Labs Acquires ABS Labs
    BridgeBio Launches CoA Therapeutics
    Marken Moves Chicago Ops To New Full Service Location
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Samsung BioLogics Details End-To-End Services
    Eisai Launches Dementia Discovery Center
    Brammer Bio, Sarepta Enter Long-term Mfg. Tie-up
    WuXi STA Enables Ascletis to Receive NDA Approval from China FDA for Ganovo
    Recipharm Acquires Sanofi’s UK CMO Biz
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Marken Moves Chicago Ops To New Full Service Location
    PCI Names VP of Global Operations Strategy and Program Mgmt.
    The Chain of Compliance
    Vetter Strikes Out on New Pathways to Further Develop the Injection Process
    ACG Offers Customizable Traceability Solutions
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    ACM Global Labs Acquires ABS Labs
    Samsung BioLogics Details End-To-End Services
    BridgeBio Launches CoA Therapeutics
    Artelo, Syngene Enter Partnership
    LakePharma, Harbour Antibodies Form Discovery Partnership
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    WuXi STA Enables Ascletis to Receive NDA Approval from China FDA for Ganovo
    Semi-Solid Dosage Forms
    PAI Readiness – A Journey, not an Event
    The Outsourcing Balancing Act
    Pii Gets Positive Inspection News from FDA and MHRA
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Vetter Pharma International GmbH
    Emergent BioSolutions, Inc.
    Jubilant HollisterStier Contract Manufacturing & Services
    Federal Equipment Company
    Halo Pharmaceutical, Inc.
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Vetter Pharma International GmbH
    Emergent BioSolutions, Inc.
    Federal Equipment Company
    Baker
    Baxter BioPharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    MannKind Ends Afrezza License with Sanofi

    Will transition development and commercialization to MannKind

    Related CONTENT
    • Afrezza Gets Panel Date
    • Sanofi, MannKind Enter Global Afrezza Pact
    • MannKind Earns $50M Sanofi Milestone
    • 3 Sanofi-Aventis
    • 3 Sanofi
    01.05.16
    MannKind Corp. has terminated its license and collaboration agreement with Sanofi-aventis U.S. for the development and commercialization of Afrezza (insulin human) Inhalation Powder. The companies will transition the development and commercialization of Afrezza from Sanofi to MannKind within 180 days.
     
    MannKind is reviewing its strategic options for Afrezza as a result of the termination of the Sanofi collaboration.
    Related Searches
    • Development
    • license
    • Drug Development
    • collaboration
    Suggested For You
    Crown Bioscience Enters Antibody Collaboration Crown Bioscience Enters Antibody Collaboration
    Regeneron, SillaJen in Clinical and Supply Pact Regeneron, SillaJen in Clinical and Supply Pact
    Domain, Pfizer in bioSensAll Alliance Domain, Pfizer in bioSensAll Alliance
    AMO Pharma, Ranedis Pharmaceuticals Form Pact AMO Pharma, Ranedis Pharmaceuticals Form Pact
    Alcami Expands Analytical Capabilities Alcami Expands Analytical Capabilities
    Bayer Strengthens U.S. Animal Health Portfolio Bayer Strengthens U.S. Animal Health Portfolio
    Two Strikes, Two Outs, or Time Out? Inhalation for Systemic Effect Two Strikes, Two Outs, or Time Out? Inhalation for Systemic Effect
    Financial Report: Evotec Financial Report: Evotec
    Top 25 Pharma and Biopharma Report Top 25 Pharma and Biopharma Report
    3 Sanofi 3 Sanofi
    3 Sanofi-Aventis 3 Sanofi-Aventis
    MannKind Earns $50M Sanofi Milestone MannKind Earns $50M Sanofi Milestone
    Sanofi, MannKind Enter Global Afrezza Pact Sanofi, MannKind Enter Global Afrezza Pact
    Afrezza Gets Panel Date Afrezza Gets Panel Date

    Related Breaking News

    • Drug Development | Drug Discovery | Industry News | R&D
      BridgeBio Launches CoA Therapeutics

      BridgeBio Launches CoA Therapeutics

      To develop novel small-molecules designed to increase CoA levels in genetic disorders where CoA deficiency is implicated
      06.14.18
    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
      Artelo, Syngene Enter Partnership

      Artelo, Syngene Enter Partnership

      For the drug discovery and clinical development of ART27.13, Artelo's Phase 2 ready, high-potency dual cannabinoid agonist
      06.14.18
    • Drug Development | Drug Discovery | Facilities | Industry News
      Eisai Launches Dementia Discovery Center

      Eisai Launches Dementia Discovery Center

      Over $100 million committed as an initial investment to establish the new 50,000 sq. ft. discovery center in Cambridge, MA
      06.14.18
    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
      Alcami Extends Workbench Laboratory Services Program

      Alcami Extends Workbench Laboratory Services Program

      To support the ongoing manufacturing and development of ZILRETTA for Flexion Therapeutics
      06.13.18
    • Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
      Microbiotica, Genentech Announce Collaboration

      Microbiotica, Genentech Announce Collaboration

      To discover, develop and commercialize biomarkers, targets and medicines for inflammatory bowel disease
      06.12.18
    • Collaborations & Alliances | Drug Development | Industry News
      BioMarin Receives Pfizer Milestone Payments

      BioMarin Receives Pfizer Milestone Payments

      Totaling $20 million, the payments were triggered by the FDA's acceptance of Pfizer's NDA for talazoparib
      06.12.18
    • Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
      Alexion, Complement Enter Partnership

      Alexion, Complement Enter Partnership

      To co-develop the preclinical C6 complement inhibitor CP010 for neurodegenerative disorders
      06.12.18
    • CRO News | Drug Development | Laboratory Testing
      LabCorp Acquires Sciformix Corp.

      LabCorp Acquires Sciformix Corp.

      Expands pharmacovigilance capabilities for post-approval safety solutions
      06.11.18
    • Bio News | Breaking News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery
      GE, XPH Enter FlexFactory Agreement

      GE, XPH Enter FlexFactory Agreement

      To scale up, digitize & accelerate manufacturing processes for their cell therapy clinical trials & future commercialization
      06.07.18
    • Bio News | Breaking News | Drug Development | Industry News
      Biogen Acquires TMS

      Biogen Acquires TMS' Phase 2 Asset for Acute Stroke

      Biogen to pay $4 million upfront and $18 million upon exercise of the option, plus milestones of up to $335 million
      06.07.18
    • Drug Development | Industry News | R&D
      InflaRx Opens New Research Facility

      InflaRx Opens New Research Facility

      Lead candidate, IFX-1 is advancing through clinical trials with Phase IIB data in hidradenitis suppurativa expected 1H19
      06.06.18
    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
      Lonza & Innosieve Enter Distribution Agreement

      Lonza & Innosieve Enter Distribution Agreement

      Lonza to sell, distribute Innosieve Diagnostics’ MuScan™ Instrument, Sieve-ID® Total Viable Count Kit and associated software
      06.04.18
    • Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Industry News | Methods Development
      NEOMED-LABS, GSK Extend Agreement

      NEOMED-LABS, GSK Extend Agreement

      NEOMED-LABS will develop immunotools, immunochemical assays, and functional assays and undertake project testing for GSK
      05.31.18
    • Bio News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
      Zai Lab, Crescendo Biologics Enter Licensing Agreement

      Zai Lab, Crescendo Biologics Enter Licensing Agreement

      Zai Lab will develop, commercialize, and manufacture a topical antibody VH domain therapeutic for inflammatory indications
      05.30.18
    • Collaborations & Alliances | Drug Development | Industry News | Methods Development
      Centogene, Aldeyra Enter Partnership

      Centogene, Aldeyra Enter Partnership

      To globally identify patients with SLS and to understand & raise awareness of the clinical spectrum of this disease
      05.30.18
    Breaking News
    • Aclaris Therapeutics Announces Key Hires
    • Recipharm, SERB Enter Agreement
    • ACM Global Labs Acquires ABS Labs
    • BridgeBio Launches CoA Therapeutics
    • Marken Moves Chicago Ops To New Full Service Location
    View Breaking News >
    CURRENT ISSUE

    June 2018
    • 19th Annual Salary & Job Satisfaction Survey
    • The Outsourcing Balancing Act
    • The Chain of Compliance
    • Traveling Toward the Intersection of Drug Development and Delivery
    • Developing Faster-to-Clinic Formulations
    • PAI Readiness – A Journey, not an Event
    • Journeying with CROs: Driving drug development efficiency
    • Pre-clinical CRO Evaluation
    • Newsmakers: Flash Therapeutics
    • DCAT Sharp Sourcing 2018
      • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    Copyright © 2018 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.